Rathbones Group’s ResMed RMD Stock Holding History

Rathbones Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,030	Closed	-$231K	–	639
2025 Q1	$231K	Hold	1,030	–	–	﹤0.01%	507
2024 Q4	$236K	Hold	1,030	–	–	﹤0.01%	505
2024 Q3	$251K	Buy	+1,030	New	+$230K	﹤0.01%	514
2024 Q2	–	Sell	-1,230	Closed	-$244K	–	637
2024 Q1	$244K	Hold	1,230	–	–	﹤0.01%	525
2023 Q4	$212K	Buy	+1,230	New	+$189K	﹤0.01%	529
2023 Q3	–	Sell	-1,100	Closed	-$240K	–	638
2023 Q2	$240K	Hold	1,100	–	–	﹤0.01%	360
2023 Q1	$241K	Hold	1,100	–	–	﹤0.01%	358
2022 Q4	$229K	Hold	1,100	–	–	﹤0.01%	364
2022 Q3	$240K	Hold	1,100	–	–	﹤0.01%	358
2022 Q2	$231K	Hold	1,100	–	–	﹤0.01%	375
2022 Q1	$267K	Hold	1,100	–	–	﹤0.01%	371
2021 Q4	$287K	Hold	1,100	–	–	﹤0.01%	368
2021 Q3	$290K	Sell	1,100 -7,700	-88%	-$2.11M	﹤0.01%	356
2021 Q2	$2.17M	Hold	8,800	–	–	0.02%	199
2021 Q1	$1.71M	Sell	8,800 -5,170	-37%	-$1.04M	0.02%	206
2020 Q4	$2.97M	Sell	13,970 -4,916	-26%	-$980K	0.04%	167
2020 Q3	$3.24M	Hold	18,886	–	–	0.06%	149
2020 Q2	$3.63M	Buy	+18,886	New	+$3.09M	0.07%	133
2020 Q1	–	Sell	-1,300	Closed	-$201K	–	347
2019 Q4	$201K	Buy	+1,300	New	+$187K	0.01%	310
2014 Q3	–	Sell	-5,100	Closed	-$258K	–	313
2014 Q2	$258K	Sell	5,100 -2,000	-28%	-$99.1K	0.02%	246
2014 Q1	$317K	Buy	+7,100	New	+$319K	0.03%	221
2013 Q4	–	Sell	-6,300	Closed	-$333K	–	254
2013 Q3	$333K	Hold	6,300	–	–	0.04%	198
2013 Q2	$284K	Buy	+6,300	New	+$299K	0.04%	191

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Rathbones Group's RMD Position: Q2 2025 in Review

Rathbones Group sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,030 shares — an estimated $231K sold.

Rathbones Group first reported a position in RMD in Q2 2013 and held it in 23 quarters. The position peaked at $3.63M in Q2 2020. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Rathbones Group reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Rathbones Group sold 1,030 ResMed shares in Q2 2025, an estimated $231K.
Rathbones Group first reported a position in ResMed in Q2 2013 and held it in 23 quarters.
Rathbones Group's ResMed position peaked at $3.63M in Q2 2020.
920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Rathbones Group's 13F filing for Q2 2025, filed 7 Aug 2025.